Pages that link to "Q48540895"
Jump to navigation
Jump to search
The following pages link to Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors (Q48540895):
Displaying 24 items.
- Thionein/metallothionein control Zn(II) availability and the activity of enzymes (Q24303229) (← links)
- Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1) (Q24304148) (← links)
- Zinc-binding cysteines: diverse functions and structural motifs. (Q30364031) (← links)
- Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. (Q30493459) (← links)
- Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy (Q33525524) (← links)
- Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease (Q33791523) (← links)
- Mechanistic similarity and diversity among the guanidine-modifying members of the pentein superfamily (Q33925308) (← links)
- Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase (Q34393366) (← links)
- Ab Initio QM/MM Free-Energy Studies of Arginine Deiminase Catalysis: The Protonation State of the Cys Nucleophile (Q34756946) (← links)
- Chemical biology of protein arginine modifications in epigenetic regulation (Q35722457) (← links)
- Mechanisms of catalysis and inhibition operative in the arginine deiminase from the human pathogen Giardia lamblia (Q36110842) (← links)
- Specific reactions of S-nitrosothiols with cysteine hydrolases: A comparative study between dimethylargininase-1 and CTP synthetase (Q36388302) (← links)
- Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. (Q36844696) (← links)
- Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. (Q37336634) (← links)
- The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. (Q37860140) (← links)
- Relationship between the architecture of zinc coordination and zinc binding affinity in proteins--insights into zinc regulation (Q38254214) (← links)
- Inhibitory zinc sites in enzymes (Q44954333) (← links)
- Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: alkenyl-amidines as new leads. (Q46243381) (← links)
- Characterization of cysteine thiol modifications based on protein microenvironments and local secondary structures (Q46261187) (← links)
- Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia (Q46982143) (← links)
- Dimethylarginine-dimethylaminohydrolase-2 (DDAH-2) does not metabolize methylarginines (Q48308299) (← links)
- Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus (Q56960652) (← links)
- Unraveling the structural and chemical features of biological short hydrogen bonds (Q90535169) (← links)
- Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer (Q93016445) (← links)